The count of CD4+ Treg cells (CD4+/CD25+/FoxP3+) was lower in the tumor with HOE642 treatment, with no changes of CD4+ T cells and CD8+ T cells (Fig. 6c). The gene discussed is CD8A; the disease is neoplasm.